BionIT Labs, the Italian/U.S. med-tech company behind the Adam's Hand prosthetic, has closed a Series A funding round, securing $6.0M in new capital. The company, which applies information technologies to bionics, aims to transform disabilities into new possibilities, focusing on improving the quality of life for upper limb amputees.
Its flagship product, Adam's Hand, is a prosthetic hand designed with a unique technology that allows fingers to automatically adapt to the shape and size of grasped objects without requiring preset grip patterns, offering users a robust, compact, and easy-to-use device with high autonomy.
